234 related articles for article (PubMed ID: 8496689)
21. Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.
Bitzan M; Klemt M; Steffens R; Müller-Wiefel DE
Infection; 1993; 21(3):140-5. PubMed ID: 8365810
[TBL] [Abstract][Full Text] [Related]
22. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
23. Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins.
Nyholm PG; Magnusson G; Zheng Z; Norel R; Binnington-Boyd B; Lingwood CA
Chem Biol; 1996 Apr; 3(4):263-75. PubMed ID: 8807854
[TBL] [Abstract][Full Text] [Related]
24. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.
Tam P; Mahfoud R; Nutikka A; Khine AA; Binnington B; Paroutis P; Lingwood C
J Cell Physiol; 2008 Sep; 216(3):750-63. PubMed ID: 18446787
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Uses of Bacterial Subunit Toxins.
Lingwood C
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
[TBL] [Abstract][Full Text] [Related]
26. Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis.
Picking WD; McCann JA; Nutikka A; Lingwood CA
Biochemistry; 1999 Jun; 38(22):7177-84. PubMed ID: 10353828
[TBL] [Abstract][Full Text] [Related]
27. Reproduction of edema disease of swine with purified Shiga-like toxin-II variant.
MacLeod DL; Gyles CL; Wilcock BP
Vet Pathol; 1991 Jan; 28(1):66-73. PubMed ID: 1826800
[TBL] [Abstract][Full Text] [Related]
28. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
29. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.
Lingwood CA
Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026
[TBL] [Abstract][Full Text] [Related]
30. Verotoxin receptor glycolipid in human renal tissue.
Boyd B; Lingwood C
Nephron; 1989; 51(2):207-10. PubMed ID: 2644572
[TBL] [Abstract][Full Text] [Related]
31. Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides.
Head S; Ramotar K; Lingwood C
Infect Immun; 1990 Jun; 58(6):1532-7. PubMed ID: 2160427
[TBL] [Abstract][Full Text] [Related]
32. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
[TBL] [Abstract][Full Text] [Related]
34. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody.
Chark D; Nutikka A; Trusevych N; Kuzmina J; Lingwood C
Eur J Biochem; 2004 Jan; 271(2):405-17. PubMed ID: 14717708
[TBL] [Abstract][Full Text] [Related]
35. Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro.
Bitzan M; Richardson S; Huang C; Boyd B; Petric M; Karmali MA
Infect Immun; 1994 Aug; 62(8):3337-47. PubMed ID: 8039905
[TBL] [Abstract][Full Text] [Related]
36. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.
Ashkenazi S; Cleary TG
J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433
[TBL] [Abstract][Full Text] [Related]
37. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
[TBL] [Abstract][Full Text] [Related]
38. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1.
Zoja C; Corna D; Farina C; Sacchi G; Lingwood C; Doyle MP; Padhye VV; Abbate M; Remuzzi G
J Lab Clin Med; 1992 Aug; 120(2):229-38. PubMed ID: 1323633
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
[TBL] [Abstract][Full Text] [Related]
40. Capping and receptor-mediated endocytosis of cell-bound verotoxin (Shiga-like toxin). 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization.
Khine AA; Lingwood CA
J Cell Physiol; 1994 Nov; 161(2):319-32. PubMed ID: 7962116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
